FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / BMC Vet Res / Lysophosphatidic acid as a regulator of endometrial connecti...
BMC veterinary research2020; 16(1); 343; doi: 10.1186/s12917-020-02562-6

Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare.

Abstract: Equine endometrosis is a chronic degenerative condition, described as endometrial fibrosis that forms in the stroma, under the basement membrane and around the endometrial glands. The role of lysophosphatidic acid (LPA) in the development of tissue fibrosis varies depending on the organ, and its profibrotic role in mare endometrosis remains unclear. The study aimed to establish the endometrial presence of LPA and its receptors (LPAR1-4), together with its effects on connective tissue growth factor (CTGF) and prostaglandins (PG) secretion from equine endometrium under physiological (estrous cycle), or pathological conditions (endometrosis). Mare endometria in the mid-luteal phase (n = 5 for each category I, IIA, IIB, III of Kenney and Doig) and in the follicular phase (n = 5 for each category I, IIA, III and n = 4 for IIB) were used. In experiment 1, the levels of LPA, LPAR1-4 mRNA level and protein abundance were investigated in endometria at different stages of endometrosis. In experiment 2, the in vitro effect of LPA (10 M) on the secretion of CTGF and PGs from endometrial tissue explants at different stages of endometrosis were determined. Results: Endometrial LPA concentration was higher in the mid-luteal phase compared to the follicular phase in category I endometrium (P < 0.01). There was an alteration in endometrial concentrations of LPA and LPAR1-4 protein abundance in the follicular phase at different stages of endometrosis (P < 0.05). Additionally, LPA increased the secretion of PGE from category I endometrium in both phases of the estrous cycle (P < 0.05). The effect of LPA on the secretion of CTGF and PGF from endometrial tissue was altered depending on different stages of endometrosis (P < 0.05). Conclusions: Our data indicate that endometrosis disturbs proper endometrial function and is associated with altered endometrial LPA concentration, its receptor expression and protein abundance, PGE/PGF ratio, and CTGF secretion in response to LPA. These changes could influence several physiological events occurring in endometrium in mare during estrous cycle and early pregnancy.
Get Full Text
Publication Date: 2020-09-17 PubMed ID: 32943074PubMed Central: PMC7499873DOI: 10.1186/s12917-020-02562-6Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the role of lysophosphatidic acid (LPA) in equine endometrosis, a chronic degenerative condition in horses. The study sought to determine the presence of LPA and its effects on endometrial growth in mares during their estrous cycle and in cases of endometrosis.

Objectives of the Research

  • The objective of this study was to ascertain the presence of LPA and its receptors (LPAR1-4) in the equine endometrium during normal physiological conditions (estrous cycle) and pathological conditions (endometrosis).
  • The research also aimed to investigate the effects of LPA on the secretion of Connective Tissue Growth Factor (CTGF) and prostaglandins (PG) from the equine endometrium in regular and pathological conditions.

Method and Experiment Design

  • The study involved equine endometria collected in both the mid-luteal phase and the follicular phase. They were categorised according to their stages of endometrosis using the Kenney and Doig classification.
  • In the first experiment, the researchers measured the levels of LPA, and the LPAR1-4 mRNA level and protein abundance in the endometria across the different endometrosis stages.
  • The second experiment focused on determining the in-vitro effect of LPA concentration on the secretion of CTGF and PGs from endometrial tissue explants at different endometrosis stages.

Findings of the Research

  • The study found that the endometrial LPA concentration was higher in the mid-luteal phase compared to the follicular phase in category I endometrium.
  • Endometrial concentrations of LPA and LPAR1-4 protein abundance varied in the follicular phase at different stages of endometrosis.
  • The study also observed that LPA increased the secretion of PGE from category I endometrium in both phases of the estrous cycle.
  • The impact of LPA on the secretion of CTGF and PGF from endometrial tissue appeared to change depending on the different stages of endometrosis.

Conclusions of the Study

  • The research concluded that endometrosis disrupts the proper functioning of the equine endometrium and is associated with altered endometrial LPA concentrations, its receptor expression and protein abundance, PGE/PGF ratio, and CTGF secretion in response to LPA.
  • These changes can have significant effects on several physiological events occurring in the mare’s endometrium during the estrous cycle and early pregnancy periods.

Cite This Article

APA
Szóstek-Mioduchowska A, Leciejewska N, Zelmańska B, Staszkiewicz-Chodor J, Ferreira-Dias G, Skarzynski D. (2020). Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare. BMC Vet Res, 16(1), 343. https://doi.org/10.1186/s12917-020-02562-6

Publication

BMC veterinary research
ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 16
Issue: 1
Pages: 343
PII: 343

Researcher Affiliations

Szóstek-Mioduchowska, Anna
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Tuwima-st 10, 10-748, Olsztyn, Poland. a.szostek-mioduchowska@pan.olsztyn.pl.
Leciejewska, Natalia
  • Department of Animal Physiology and Biochemistry and Biostructure, Faculty of Veterinary Medicine and Animal Science, Poznan University of Life Sciences, Poznan, Poland.
Zelmańska, Beata
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Tuwima-st 10, 10-748, Olsztyn, Poland.
Staszkiewicz-Chodor, Joanna
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Tuwima-st 10, 10-748, Olsztyn, Poland.
Ferreira-Dias, Graça
  • CIISA, Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal.
Skarzynski, Dariusz
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Tuwima-st 10, 10-748, Olsztyn, Poland.

MeSH Terms

  • Animals
  • Connective Tissue Growth Factor / metabolism
  • Dinoprostone / metabolism
  • Endometriosis / metabolism
  • Endometriosis / veterinary
  • Endometrium / metabolism
  • Endometrium / pathology
  • Estrous Cycle / metabolism
  • Female
  • Fibrosis
  • Horse Diseases / metabolism
  • Horse Diseases / pathology
  • Horses
  • Lysophospholipids / metabolism
  • RNA, Messenger / metabolism
  • Receptors, Lysophosphatidic Acid / metabolism
  • Uterine Diseases / veterinary

Grant Funding

  • MAESTRO No2011/02/A/NZ5/00338 / Narodowe Centrum Nauki
  • 005/RID/2018/19 / Ministerstwo Nauki i Szkolnictwa Wyu017cszego

Conflict of Interest Statement

The authors have declared no competing interests.

References

This article includes 64 references
  1. Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.. Prostaglandins Other Lipid Mediat 2010 Apr;91(3-4):130-8.
    doi: 10.1016/j.prostaglandins.2009.02.002pmc: PMC2845529pubmed: 20331961google scholar: lookup
  2. Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling.. Bioessays 2004 Aug;26(8):870-81.
    doi: 10.1002/bies.20081pubmed: 15273989google scholar: lookup
  3. Yung YC, Stoddard NC, Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology.. J Lipid Res 2014 Jul;55(7):1192-214.
    doi: 10.1194/jlr.R046458pmc: PMC4076099pubmed: 24643338google scholar: lookup
  4. Hecht JH, Weiner JA, Post SR, Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.. J Cell Biol 1996 Nov;135(4):1071-83.
    doi: 10.1083/jcb.135.4.1071pmc: PMC2133395pubmed: 8922387google scholar: lookup
  5. Contos JJ, Chun J. The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern.. Gene 2001 Apr 18;267(2):243-53.
    doi: 10.1016/S0378-1119(01)00410-3pubmed: 11313151google scholar: lookup
  6. Anliker B, Chun J. Cell surface receptors in lysophospholipid signaling.. Semin Cell Dev Biol 2004 Oct;15(5):457-65.
    doi: 10.1016/j.semcdb.2004.05.005pubmed: 15271291google scholar: lookup
  7. Noguchi K, Ishii S, Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.. J Biol Chem 2003 Jul 11;278(28):25600-6.
    doi: 10.1074/jbc.M302648200pubmed: 12724320google scholar: lookup
  8. Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H, Aoki J, Chun J. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing.. Nature 2005 May 5;435(7038):104-8.
    doi: 10.1038/nature03505pmc: PMC1369590pubmed: 15875025google scholar: lookup
  9. Seo H, Kim M, Choi Y, Lee CK, Ka H. Analysis of lysophosphatidic acid (LPA) receptor and LPA-induced endometrial prostaglandin-endoperoxide synthase 2 expression in the porcine uterus.. Endocrinology 2008 Dec;149(12):6166-75.
    doi: 10.1210/en.2008-0354pubmed: 18703629google scholar: lookup
  10. Liszewska E, Reinaud P, Dubois O, Charpigny G. Lysophosphatidic acid receptors in ovine uterus during estrous cycle and early pregnancy and their regulation by progesterone.. Domest Anim Endocrinol 2012 Jan;42(1):31-42.
    doi: 10.1016/j.domaniend.2011.08.003pubmed: 22032854google scholar: lookup
  11. Boruszewska D, Kowalczyk-Zieba I, Sinderewicz E, Grycmacher K, Staszkiewicz J, Woclawek-Potocka I. The effect of lysophosphatidic acid together with interferon tau on the global transcriptomic profile in bovine endometrial cells.. Theriogenology 2017 Apr 1;92:111-120.
    doi: 10.1016/j.theriogenology.2017.01.021pubmed: 28237325google scholar: lookup
  12. Chen SU, Chou CH, Lee H, Ho CH, Lin CW, Yang YS. Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome.. J Clin Endocrinol Metab 2008 Mar;93(3):935-43.
    doi: 10.1210/jc.2007-1512pubmed: 18171700google scholar: lookup
  13. Sinderewicz E, Grycmacher K, Boruszewska D, Kowalczyk-Zięba I, Staszkiewicz J, Ślężak T, Woclawek-Potocka I. Bovine ovarian follicular growth and development correlate with lysophosphatidic acid expression.. Theriogenology 2018 Jan 15;106:1-14.
    doi: 10.1016/j.theriogenology.2017.09.027pubmed: 29028570google scholar: lookup
  14. Sinderewicz E, Grycmacher K, Boruszewska D, Kowalczyk-Zięba I, Yamamoto Y, Yoshimoto Y, Woclawek-Potocka I. Lysophosphatidic Acid Synthesis and its Receptors' Expression in the Bovine Oviduct During the Oestrous Cycle.. Reprod Domest Anim 2016 Aug;51(4):541-9.
    doi: 10.1111/rda.12717pubmed: 27335048google scholar: lookup
  15. Iwasawa Y, Fujii T, Nagamatsu T, Kawana K, Okudaira S, Miura S, Matsumoto J, Tomio A, Hyodo H, Yamashita T, Oda K, Kozuma S, Aoki J, Yatomi Y, Taketani Y. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.. Am J Reprod Immunol 2009 Aug;62(2):90-5.
    doi: 10.1111/j.1600-0897.2009.00715.xpubmed: 19614625google scholar: lookup
  16. Woclawek-Potocka I, Komiyama J, Saulnier-Blache JS, Brzezicka E, Bah MM, Okuda K, Skarzynski DJ. Lysophosphatic acid modulates prostaglandin secretion in the bovine uterus.. Reproduction 2009 Jan;137(1):95-105.
    doi: 10.1530/REP-08-0209pubmed: 18829944google scholar: lookup
  17. Liszewska E, Reinaud P, Billon-Denis E, Dubois O, Robin P, Charpigny G. Lysophosphatidic acid signaling during embryo development in sheep: involvement in prostaglandin synthesis.. Endocrinology 2009 Jan;150(1):422-34.
    doi: 10.1210/en.2008-0749pubmed: 18772233google scholar: lookup
  18. McCracken JA, Custer EE, Lamsa JC. Luteolysis: a neuroendocrine-mediated event.. Physiol Rev 1999 Apr;79(2):263-323.
    doi: 10.1152/physrev.1999.79.2.263pubmed: 10221982google scholar: lookup
  19. Jabbour HN, Boddy SC. Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway.. J Clin Endocrinol Metab 2003 Sep;88(9):4481-7.
    doi: 10.1210/jc.2003-030297pubmed: 12970327google scholar: lookup
  20. Milne SA, Jabbour HN. Prostaglandin (PG) F(2alpha) receptor expression and signaling in human endometrium: role of PGF(2alpha) in epithelial cell proliferation.. J Clin Endocrinol Metab 2003 Apr;88(4):1825-32.
    doi: 10.1210/jc.2002-021368pubmed: 12679480google scholar: lookup
  21. Kennedy TG, Gillio-Meina C, Phang SH. Prostaglandins and the initiation of blastocyst implantation and decidualization.. Reproduction 2007 Nov;134(5):635-43.
    doi: 10.1530/REP-07-0328pubmed: 17965253google scholar: lookup
  22. Tangkijvanich P, Melton AC, Chitapanarux T, Han J, Yee HF. Platelet-derived growth factor-BB and lysophosphatidic acid distinctly regulate hepatic myofibroblast migration through focal adhesion kinase.. Exp Cell Res 2002 Nov 15;281(1):140-7.
    doi: 10.1006/excr.2002.5657pubmed: 12441137google scholar: lookup
  23. Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.. Nat Med 2008 Jan;14(1):45-54.
    doi: 10.1038/nm1685pubmed: 18066075google scholar: lookup
  24. Ninou I, Magkrioti C, Aidinis V. Autotaxin in Pathophysiology and Pulmonary Fibrosis.. Front Med (Lausanne) 2018;5:180.
    doi: 10.3389/fmed.2018.00180pmc: PMC6008954pubmed: 29951481google scholar: lookup
  25. Gan L, Xue JX, Li X, Liu DS, Ge Y, Ni PY, Deng L, Lu Y, Jiang W. Blockade of lysophosphatidic acid receptors LPAR1/3 ameliorates lung fibrosis induced by irradiation.. Biochem Biophys Res Commun 2011 May 27;409(1):7-13.
    doi: 10.1016/j.bbrc.2011.04.084pubmed: 21545790google scholar: lookup
  26. Sakai N, Chun J, Duffield JS, Wada T, Luster AD, Tager AM. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.. FASEB J 2013 May;27(5):1830-46.
    doi: 10.1096/fj.12-219378pmc: PMC3633809pubmed: 23322166google scholar: lookup
  27. Diel de Amorim M, Khan FA, Chenier TS, Scholtz EL, Hayes MA. Analysis of the uterine flush fluid proteome of healthy mares and mares with endometritis or fibrotic endometrial degeneration.. Reprod Fertil Dev 2020 Mar;32(6):572-581.
    doi: 10.1071/RD19085pubmed: 31987068google scholar: lookup
  28. Inoue CN, Forster HG, Epstein M. Effects of lysophosphatidic acid, a novel lipid mediator, on cytosolic Ca2+ and contractility in cultured rat mesangial cells.. Circ Res 1995 Nov;77(5):888-96.
    doi: 10.1161/01.RES.77.5.888pubmed: 7554142google scholar: lookup
  29. Gaits F, Salles JP, Chap H. Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells.. Kidney Int 1997 Apr;51(4):1022-7.
    doi: 10.1038/ki.1997.143pubmed: 9083266google scholar: lookup
  30. Kenney RM. Cyclic and pathologic changes of the mare endometrium as detected by biopsy, with a note on early embryonic death.. J Am Vet Med Assoc 1978 Feb 1;172(3):241-62.
    pubmed: 621166
  31. Kenney RM, Doig PA. Equine endometrial biopsy. In: Morrow DA, editor. Current Therapy in Theriogenology 2. Philadelphia: Saunders WB; 1986. pp. 726–729.
  32. Hoffmann C, Ellenberger C, Mattos RC, Aupperle H, Dhein S, Stief B, Schoon HA. The equine endometrosis: new insights into the pathogenesis.. Anim Reprod Sci 2009 Apr;111(2-4):261-78.
    doi: 10.1016/j.anireprosci.2008.03.019pubmed: 18468817google scholar: lookup
  33. Lehmann J, Ellenberger C, Hoffmann C, Bazer FW, Klug J, Allen WR, Sieme H, Schoon HA. Morpho-functional studies regarding the fertility prognosis of mares suffering from equine endometrosis.. Theriogenology 2011 Oct 15;76(7):1326-36.
    doi: 10.1016/j.theriogenology.2011.06.001pubmed: 21855986google scholar: lookup
  34. Szóstek AZ, Siemieniuch MJ, Lukasik K, Galvão AM, Ferreira-Dias GM, Skarzynski DJ. mRNA transcription of prostaglandin synthases and their products in the equine endometrium in the course of fibrosis.. Theriogenology 2012 Sep 1;78(4):768-76.
    doi: 10.1016/j.theriogenology.2012.03.024pubmed: 22578628google scholar: lookup
  35. Szóstek AZ, Lukasik K, Galvão AM, Ferreira-Dias GM, Skarzynski DJ. Impairment of the interleukin system in equine endometrium during the course of endometrosis.. Biol Reprod 2013 Oct;89(4):79.
    doi: 10.1095/biolreprod.113.109447pubmed: 23946535google scholar: lookup
  36. Woclawek-Potocka I, Kowalczyk-Zieba I, Skarzynski DJ. Lysophosphatidic acid action during early pregnancy in the cow: in vivo and in vitro studies.. J Reprod Dev 2010 Aug;56(4):411-20.
    doi: 10.1262/jrd.09-205Kpubmed: 20431249google scholar: lookup
  37. Kim D, Li HY, Lee JH, Oh YS, Jun HS. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling.. Exp Mol Med 2019 Feb 15;51(2):1-10.
    pmc: PMC6377648pubmed: 30770784doi: 10.1038/s12276-019-0217-3google scholar: lookup
  38. Yasuda D, Kobayashi D, Akahoshi N, Ohto-Nakanishi T, Yoshioka K, Takuwa Y, Mizuno S, Takahashi S, Ishii S. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.. J Clin Invest 2019 Jul 23;129(10):4332-4349.
    doi: 10.1172/JCI121955pmc: PMC6763231pubmed: 31335323google scholar: lookup
  39. Liu S, Murph M, Panupinthu N, Mills GB. ATX-LPA receptor axis in inflammation and cancer.. Cell Cycle 2009 Nov 15;8(22):3695-701.
    doi: 10.4161/cc.8.22.9937pmc: PMC4166520pubmed: 19855166google scholar: lookup
  40. Demoyer JS, Skalak TC, Durieux ME. Lysophosphatidic acid enhances healing of acute cutaneous wounds in the mouse.. Wound Repair Regen 2000 Nov-Dec;8(6):530-7.
    doi: 10.1046/j.1524-475x.2000.00530.xpubmed: 11208180google scholar: lookup
  41. Stortelers C, Kerkhoven R, Moolenaar WH. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling.. BMC Genomics 2008 Aug 14;9:387.
    doi: 10.1186/1471-2164-9-387pmc: PMC2536681pubmed: 18702810google scholar: lookup
  42. Moussad EE, Rageh MA, Wilson AK, Geisert RD, Brigstock DR. Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero-placental interface during early pregnancy in the pig.. Mol Pathol 2002 Jun;55(3):186-92.
    doi: 10.1136/mp.55.3.186pmc: PMC1187172pubmed: 12032230google scholar: lookup
  43. Lillie B, Traficante E, Walker ME, Quinn BA, Arroyo L, Waelchli RO, Betteridge KJ, Hayes MA. Endometrial expression of capsule-associated proteins and cytokines during the third week of pregnancy in mares. Anim Reprod Sci 2010;121:254–256.
    doi: 10.1016/j.anireprosci.2010.04.161google scholar: lookup
  44. Hayes MA, Quinn BA, Lillie BN, Côté O, Bienzle D, Waelchli RO, Betteridge KJ. Changes in various endometrial proteins during cloprostenol-induced failure of early pregnancy in mares. Anim Reprod 2012;9:723–741.
  45. Klein C. Novel equine conceptus?endometrial interactions on Day 16 of pregnancy based on RNA sequencing.. Reprod Fertil Dev 2015 May 5;.
    doi: 10.1071/RD14489pubmed: 25940503google scholar: lookup
  46. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T, Yanase M, Tejima K, Nishikawa T, Arai M, Arai H, Omata M, Fujiwara K, Yatomi Y. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.. J Clin Gastroenterol 2007 Jul;41(6):616-23.
    doi: 10.1097/01.mcg.0000225642.90898.0epubmed: 17577119google scholar: lookup
  47. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Tomiya T, Tejima K, Nishikawa T, Arai M, Yanase M, Aoki J, Arai H, Omata M, Fujiwara K, Yatomi Y. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.. Life Sci 2007 Sep 1;81(12):1009-15.
    doi: 10.1016/j.lfs.2007.08.013pubmed: 17850827google scholar: lookup
  48. Komachi M, Damirin A, Malchinkhuu E, Mogi C, Tobo M, Ohta H, Sato K, Tomura H, Okajima F. Signaling pathways involved in DNA synthesis and migration in response to lysophosphatidic acid and low-density lipoprotein in coronary artery smooth muscle cells.. Vascul Pharmacol 2009 May-Jun;50(5-6):178-84.
    doi: 10.1016/j.vph.2009.01.004pubmed: 19563736google scholar: lookup
  49. Oga T, Matsuoka T, Yao C, Nonomura K, Kitaoka S, Sakata D, Kita Y, Tanizawa K, Taguchi Y, Chin K, Mishima M, Shimizu T, Narumiya S. Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta.. Nat Med 2009 Dec;15(12):1426-30.
    doi: 10.1038/nm.2066pubmed: 19966781google scholar: lookup
  50. Ding WY, Ti Y, Wang J, Wang ZH, Xie GL, Shang YY, Tang MX, Zhang Y, Zhang W, Zhong M. Prostaglandin F2α facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor/protein kinase C/Rho kinase pathway independent of transforming growth factor β1.. Int J Biochem Cell Biol 2012 Jun;44(6):1031-9.
    doi: 10.1016/j.biocel.2012.03.013pubmed: 22484488google scholar: lookup
  51. Aihara K, Handa T, Oga T, Watanabe K, Tanizawa K, Ikezoe K, Taguchi Y, Sato H, Chin K, Nagai S, Narumiya S, Wells AU, Mishima M. Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.. PLoS One 2013;8(6):e66017.
    doi: 10.1371/journal.pone.0066017pmc: PMC3679025pubmed: 23776595google scholar: lookup
  52. Szóstek-Mioduchowska AZ, Baclawska A, Rebordão MR, Ferreira-Dias G, Skarzynski DJ. Prostaglandins effect on matrix metallopeptidases and collagen in mare endometrial fibroblasts.. Theriogenology 2020 Sep 1;153:74-84.
    doi: 10.1016/j.theriogenology.2020.04.040pubmed: 32442743google scholar: lookup
  53. Ito Y, Goldschmeding R, Kasuga H, Claessen N, Nakayama M, Yuzawa Y, Sawai A, Matsuo S, Weening JJ, Aten J. Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis.. Am J Physiol Renal Physiol 2010 Sep;299(3):F545-58.
    doi: 10.1152/ajprenal.00120.2009pubmed: 20576680google scholar: lookup
  54. Dendooven A, Gerritsen KG, Nguyen TQ, Kok RJ, Goldschmeding R. Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis.. Biomarkers 2011 Jun;16(4):289-301.
    doi: 10.3109/1354750X.2011.561366pubmed: 21595567google scholar: lookup
  55. Xing X, Li Z, Yu Z, Cheng G, Li D, Li Z. Effects of connective tissue growth factor (CTGF/CCN2) on condylar chondrocyte proliferation, migration, maturation, differentiation and signalling pathway.. Biochem Biophys Res Commun 2018 Jan 1;495(1):1447-1453.
    doi: 10.1016/j.bbrc.2017.11.190pubmed: 29198711google scholar: lookup
  56. Hall-Glenn F, Lyons KM. Roles for CCN2 in normal physiological processes.. Cell Mol Life Sci 2011 Oct;68(19):3209-17.
    doi: 10.1007/s00018-011-0782-7pmc: PMC3670951pubmed: 21858450google scholar: lookup
  57. Rebordão MR, Galvão A, Szóstek A, Amaral A, Mateus L, Skarzynski DJ, Ferreira-Dias G. Physiopathologic mechanisms involved in mare endometrosis.. Reprod Domest Anim 2014 Oct;49 Suppl 4:82-7.
    doi: 10.1111/rda.12397pubmed: 25277436google scholar: lookup
  58. Rebordão MR, Pereira C, Galvão A, Bravo PP, Szóstek A, Skarzynski DJ, Ferreira-Dias G. What is new on the physiopathology of endometrosis in the mare?. Pferdeheilkunde 2014;30:15–18.
    doi: 10.21836/PEM20140102google scholar: lookup
  59. Roberto da Costa RP, Serrão PM, Monteiro S, Pessa P, Silva JR, Ferreira-Dias G. Caspase-3-mediated apoptosis and cell proliferation in the equine endometrium during the oestrous cycle.. Reprod Fertil Dev 2007;19(8):925-32.
    doi: 10.1071/RD06159pubmed: 18076824google scholar: lookup
  60. Rebordão MR, Amaral A, Lukasik K, Szóstek-Mioduchowska A, Pinto-Bravo P, Galvão A, Skarzynski DJ, Ferreira-Dias G. Impairment of the antifibrotic prostaglandin E(2) pathway may influence neutrophil extracellular traps-induced fibrosis in the mare endometrium.. Domest Anim Endocrinol 2019 Apr;67:1-10.
    doi: 10.1016/j.domaniend.2018.10.004pubmed: 30522057google scholar: lookup
  61. Riddle WT, LeBlanc MM, Stromberg AJ. Relationships between uterine culture, cytology and pregnancy rates in a Thoroughbred practice.. Theriogenology 2007 Aug;68(3):395-402.
    doi: 10.1016/j.theriogenology.2007.05.050pubmed: 17583785google scholar: lookup
  62. Saulnier-Blache JS, Girard A, Simon MF, Lafontan M, Valet P. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.. J Lipid Res 2000 Dec;41(12):1947-51.
    pmc: PMC2020493pubmed: 11108727
  63. Szóstek-Mioduchowska AZ, Lukasik K, Skarzynski DJ, Okuda K. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts.. Theriogenology 2019 Jan 15;124:9-17.
    doi: 10.1016/j.theriogenology.2018.10.005pubmed: 30321755google scholar: lookup
  64. Zhao S, Fernald RD. Comprehensive algorithm for quantitative real-time polymerase chain reaction.. J Comput Biol 2005 Oct;12(8):1047-64.
    pmc: PMC2716216pubmed: 16241897doi: 10.1089/cmb.2005.12.1047google scholar: lookup

Citations

This article has been cited 4 times.
  1. Zdrojkowski Ł, Jasiński T, Ferreira-Dias G, Pawliński B, Domino M. The Role of NF-κB in Endometrial Diseases in Humans and Animals: A Review. Int J Mol Sci 2023 Feb 2;24(3).
    doi: 10.3390/ijms24032901pubmed: 36769226google scholar: lookup
  2. Jasiński T, Zdrojkowski Ł, Ferreira-Dias G, Kautz E, Juszczuk-Kubiak E, Domino M. Molecular Mechanism of Equine Endometrosis: The NF-κB-Dependent Pathway Underlies the Ovarian Steroid Receptors' Dysfunction. Int J Mol Sci 2022 Jul 1;23(13).
    doi: 10.3390/ijms23137360pubmed: 35806363google scholar: lookup
  3. Katila T, Ferreira-Dias G. Evolution of the Concepts of Endometrosis, Post Breeding Endometritis, and Susceptibility of Mares. Animals (Basel) 2022 Mar 19;12(6).
    doi: 10.3390/ani12060779pubmed: 35327176google scholar: lookup
  4. Piotrowska-Tomala KK, Szóstek-Mioduchowska A, Jonczyk AW, Drzewiecka EM, Wrobel MH, Hojo T, Ferreira-Dias G, Skarzynski DJ. The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares. BMC Vet Res 2024 Dec 19;20(1):571.
    doi: 10.1186/s12917-024-04384-2pubmed: 39696406google scholar: lookup
Subscribe to our newsletter
Join 99,359 horse owners like you who receive our email updates on horse health and nutrition.